98 results
8-K
EX-1.1
MRSN
Mersana Therapeutics Inc
28 Feb 24
Entry into a Material Definitive Agreement
4:08pm
of the assets of each Plan that is subject to the funding rules of Section 412 of the Code of Section 302 of ERISA exceeds the present value of all benefits … be subject in such proportion as shall be appropriate to reflect the relative benefits received by the Company on the one hand and Cowen on the other
424B5
MRSN
Mersana Therapeutics Inc
28 Feb 24
Prospectus supplement for primary offering
4:07pm
-1660 and XMT-2056;
the potential benefits of our existing strategic collaborations and our ability to enter into additional selective strategic … today’s standards of care.
Although currently approved ADCs are providing substantial benefits to certain patient populations and more product candidates
POS AM
MRSN
Mersana Therapeutics Inc
28 Feb 24
Prospectus update (post-effective amendment)
4:05pm
activities, preclinical studies and clinical trials, including our Phase 1 clinical trials of XMT-1660 and XMT-2056;
the potential benefits of our existing … .
Although currently approved ADCs are providing substantial benefits to certain patient populations and more product candidates are in development, we
POSASR
bny43qy7ytw44
28 Feb 24
Automatic shelf registration (post-effective amendment)
8:43am
8-K
EX-99.1
w6eqs7474pqm9ux9
28 Feb 24
Mersana Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2023 Financial Results
7:07am
8-K
EX-99.1
oxmx 2ilnaeto4l
5 Jan 24
Regulation FD Disclosure
8:06am
8-K
EX-99.1
9uiyciu5a0rkcc3
7 Nov 23
Mersana Therapeutics Provides Business Update and Announces Third Quarter 2023 Financial Results
7:18am
8-K
EX-99.1
h8lqm8a0uv
31 Oct 23
Mersana Therapeutics Announces FDA has Lifted Clinical Hold on Phase 1 Clinical Trial of XMT-2056
8:12am
8-K
EX-99.1
1jhc2oxl nmvdiracrag
8 Aug 23
Mersana Therapeutics Announces Second Quarter 2023 Financial Results
8:04am
8-K
sqvk tuzfxxnfsb97
8 Aug 23
Mersana Therapeutics Announces Second Quarter 2023 Financial Results
8:04am
8-K
6tlph2 phrqp5g
27 Jul 23
Results of Operations and Financial Condition
7:32am